...

首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Reply to 'Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing'

【24h】

Reply to 'Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing'

机译：回复“直接抗病毒药物和肝细胞癌（HCC）早期复发的风险：事不宜迟，一事无成”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Hepatology: The Journal of the European Association for the Study of the Liver》 |2016年第4期|共2页
作者
Reig Maria; Torres Ferran; Marino Zoe; Forns Xavier; Bruix Jordi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to "Direct antiviral agents and risk for hepatocellular carcinoma (HCC) early recurrence: Much ado about nothing" [J] . Reig Maria, Torres Ferran, Marino Zoe, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2016,第4期

机译：回复“直接抗病毒药物和肝细胞癌（HCC）早期复发的风险：事不宜迟，一事无成”
2. Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing [J] . Camma Calogero, Cabibbo Giuseppe, Craxi Antonio Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2016,第4期

机译：直接抗病毒药物和HCC早期复发的风险：事不宜迟
3. Can We Move on From the Discussion of Direct Antiviral Agents and Risk of Hepatocellular Carcinoma Recurrence? [J] . Nault Jean-Charles, Nahon Pierre Gastroenterology . 2019,第6期

机译：我们可以从讨论直接抗病毒剂和肝细胞癌复发的风险吗？
4. The changing but continued role of surgery in the management of liver tumours Hepatoblastoma (HB) and Hepatocellular Carcinoma (HCC) in children and adolescents in the -light of new results from the SIOPEL Studies- past experience and future perspectives [C] . . 2006

机译：根据SIOPEL研究的新结果-过去的经验和未来的观点，外科手术在儿童和青少年肝肿瘤肝母细胞瘤（HB）和肝细胞癌（HCC）处理中的作用不断变化，但仍在继续
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group [O] . Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, -1

机译：治愈肝细胞癌后无干扰素直接作用抗病毒治疗丙型肝炎是否会导致肝癌的意外复发？日本红十字会肝脏研究小组的多中心研究
7. Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group [O] . Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, 2018

机译：在治疗肝细胞癌后，是否对丙型肝炎进行丙型肝炎的干扰素直接抗病毒治疗导致HCC的意外复发？日本红十字医院肝脏研究组的多中心研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号